Details for New Drug Application (NDA): 085130
✉ Email this page to a colleague
NDA 085130 describes NITROFURAZONE, which is a drug marketed by Ambix, Lannett, Perrigo New York, Taro, and Wendt, and is included in seven NDAs. Additional details are available on the NITROFURAZONE profile page.
The generic ingredient in NITROFURAZONE is nitrofurazone. There are four drug master file entries for this compound. Additional details are available on the nitrofurazone profile page.
The generic ingredient in NITROFURAZONE is nitrofurazone. There are four drug master file entries for this compound. Additional details are available on the nitrofurazone profile page.
Summary for 085130
| Tradename: | NITROFURAZONE |
| Applicant: | Perrigo New York |
| Ingredient: | nitrofurazone |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 085130
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 0.2% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
